Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Circulating tumor DNA to monitor metastatic breast cancer.

Literature DB >> 23822788

Circulating tumor DNA to monitor metastatic breast cancer.

Sarah-Jane Dawson, Nitzan Rosenfeld, Carlos Caldas.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2013 PMID： 23822788 DOI： 10.1056/NEJMc1306040

Source DB: PubMed Journal: N Engl J Med ISSN： 0028-4793 Impact factor: 91.245

Keyword Cloud
Cited

× No keyword cloud information.

44 in total

Review 1. The clinical role of 'liquid biopsy' in hepatocellular carcinoma.

Authors: Jessica A Howell; Rohini Sharma
Journal: Hepat Oncol Date: 2015-11-30

2. Somatic mutation detection using various targeted detection assays in paired samples of circulating tumor DNA, primary tumor and metastases from patients undergoing resection of colorectal liver metastases.

Authors: Nick Beije; Jean C Helmijr; Marjolein J A Weerts; Corine M Beaufort; Matthew Wiggin; Andre Marziali; Cornelis Verhoef; Stefan Sleijfer; Maurice P H M Jansen; John W M Martens
Journal: Mol Oncol Date: 2016-12 Impact factor: 6.603

Review 3. [Liquid biopsy analysis using cell-free DNA (cfDNA): Opportunities and limitations].

Authors: E Dahl; V Kloten
Journal: Pathologe Date: 2015-11 Impact factor: 1.011

4. Monitoring of Serum DNA Methylation as an Early Independent Marker of Response and Survival in Metastatic Breast Cancer: TBCRC 005 Prospective Biomarker Study.

Authors: Kala Visvanathan; MaryJo S Fackler; Zhe Zhang; Zoila A Lopez-Bujanda; Stacie C Jeter; Lori J Sokoll; Elizabeth Garrett-Mayer; Leslie M Cope; Christopher B Umbricht; David M Euhus; Andres Forero; Anna M Storniolo; Rita Nanda; Nancy U Lin; Lisa A Carey; James N Ingle; Saraswati Sukumar; Antonio C Wolff
Journal: J Clin Oncol Date: 2016-11-21 Impact factor: 44.544

Review 5. Advances in liquid biopsy using circulating tumor cells and circulating cell-free tumor DNA for detection and monitoring of breast cancer.

Authors: Xiaofen Zhang; Shaoqing Ju; Xudong Wang; Hui Cong
Journal: Clin Exp Med Date: 2019-06-12 Impact factor: 3.984

Circulating tumor DNA to monitor metastatic breast cancer.

Review 1. The clinical role of 'liquid biopsy' in hepatocellular carcinoma.

2. Somatic mutation detection using various targeted detection assays in paired samples of circulating tumor DNA, primary tumor and metastases from patients undergoing resection of colorectal liver metastases.

Review 3. [Liquid biopsy analysis using cell-free DNA (cfDNA): Opportunities and limitations].

4. Monitoring of Serum DNA Methylation as an Early Independent Marker of Response and Survival in Metastatic Breast Cancer: TBCRC 005 Prospective Biomarker Study.

Review 5. Advances in liquid biopsy using circulating tumor cells and circulating cell-free tumor DNA for detection and monitoring of breast cancer.

6. Clinical relevance of circulating KRAS mutated DNA in plasma from patients with advanced pancreatic cancer.

Review 7. Estrogen receptor (ER) α mutations in breast cancer: hidden in plain sight.

Review 8. Developing biomarker-specific end points in lung cancer clinical trials.

Review 9. Blood-based analyses of cancer: circulating tumor cells and circulating tumor DNA.

10. Molecular classification of breast cancer.